Andrei Floroiu is the founder of Vaxart. Vaxart has raised $181M in total funding. Based in South San Francisco, California.
Andrei Floroiu is the CEO of Vaxart, a biotechnology company focused on developing oral, tablet-based vaccines for various infectious diseases. He has overseen the company's clinical trials, including Phase 2 studies for its COVID-19 vaccine and a human challenge study for norovirus.
Full founder directory · Investor directory · Company funding database · Fundraising library